Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2010 1
2011 1
2012 6
2013 1
2014 5
2015 5
2016 6
2017 5
2018 6
2019 5
2020 13
2021 10
2022 5
2023 6
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

72 results

Results by year

Filters applied: . Clear all
Page 1
NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial.
Wainberg ZA, Melisi D, Macarulla T, Pazo Cid R, Chandana SR, De La Fouchardière C, Dean A, Kiss I, Lee WJ, Goetze TO, Van Cutsem E, Paulson AS, Bekaii-Saab T, Pant S, Hubner RA, Xiao Z, Chen H, Benzaghou F, O'Reilly EM. Wainberg ZA, et al. Among authors: kiss i. Lancet. 2023 Oct 7;402(10409):1272-1281. doi: 10.1016/S0140-6736(23)01366-1. Epub 2023 Sep 11. Lancet. 2023. PMID: 37708904 Free article. Clinical Trial.
Hepatocellular carcinoma future treatment options.
Jiří T, Igor K, Mba. Jiří T, et al. Among authors: igor k. Klin Onkol. 2020 Fall;33(Supplementum 3):26-29. doi: 10.14735/amko20203S26. Klin Onkol. 2020. PMID: 33213162 Review. English.
Editorial: Women in gastrointestinal cancers, volume II: 2022.
Hamdy NM, Bosca L, Singh SM, Reddy Bonam S, Kiss I, Kumar DP, Banerjee A. Hamdy NM, et al. Among authors: kiss i. Front Oncol. 2023 May 11;13:1192814. doi: 10.3389/fonc.2023.1192814. eCollection 2023. Front Oncol. 2023. PMID: 37265801 Free PMC article. No abstract available.
Impact of Immunotherapy on Real-World Survival Outcomes in Metastatic Renal Cell Carcinoma.
Poprach A, Kiss I, Stanik M, Barusova T, Pospisilova L, Fiala O, Kopecky J, Richter I, Melichar B, Studentova H, Lakomy R, Holanek M, Rozsypalova A, Zemanková A, Svoboda M, Buchler T. Poprach A, et al. Among authors: kiss i. Target Oncol. 2023 Nov;18(6):893-903. doi: 10.1007/s11523-023-01013-0. Epub 2023 Nov 13. Target Oncol. 2023. PMID: 37957520
Second primary malignancies in colorectal cancer patients.
Halamkova J, Kazda T, Pehalova L, Gonec R, Kozakova S, Bohovicova L, Krakorova DA, Slaby O, Demlova R, Svoboda M, Kiss I. Halamkova J, et al. Among authors: kiss i. Sci Rep. 2021 Feb 2;11(1):2759. doi: 10.1038/s41598-021-82248-7. Sci Rep. 2021. PMID: 33531585 Free PMC article.
Optimized procedure for high-throughput transcriptome profiling of small extracellular vesicles isolated from low volume serum samples.
Vychytilova-Faltejskova P, Vilmanova S, Pifkova L, Catela Ivković T, Mᶏdrzyk M, Jugas R, Machackova T, Kotoucek J, Sachlova M, Bohovicova L, Stanek T, Halamkova J, Kiss I, Slaby O. Vychytilova-Faltejskova P, et al. Among authors: kiss i. Clin Chem Lab Med. 2023 Jul 31;62(1):157-167. doi: 10.1515/cclm-2023-0610. Print 2024 Jan 26. Clin Chem Lab Med. 2023. PMID: 37505924 Free article.
72 results